Clinical trial
Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at…
NCT00462865 · Brown University, Other · Terminated
Key facts
| NCT number | NCT00462865 |
|---|---|
| Title | Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse |
| Official title | A Phase II Study of Adjuvant Gemcitabine/Capecitabine and Bevacizumab for Patients Treated Neoadjuvantly Chemotherapy for Early Stage Breast Cancer With High Risk for Relapse |
| Lead sponsor | Brown University, Other |
| Collaborators | Women and Infants Hospital of Rhode Island Rhode Island Hospital The Miriam Hospital Memorial Hospital of Rhode Island University of New Mexico Cancer Center |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine and Capecitabine and Avastin |
| Enrollment | 18 |
| Start date | Nov 1, 2007 |
| Primary completion | Mar 1, 2012 |
| Completion | Jan 1, 2014 |
| First posted | Apr 19, 2007 |
| Last update posted | Apr 9, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: